Detection of Quorum-Sensing Molecules for Pathogenic Molecules Using Cell-Based and Cell-Free Biosensors

Since the discovery and subsequent use of penicillin, antibiotics have been used to treat most bacterial infections in the U.S. Over time, the repeated prescription of many antibiotics has given rise to many antibiotic-resistant microbes. A bacterial strain becomes resistant by horizontal gene trans...

Full description

Bibliographic Details
Main Authors: Craig Miller, Jordon Gilmore
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/5/259
id doaj-c787e5dc8be64781ae1704e5949947b8
record_format Article
spelling doaj-c787e5dc8be64781ae1704e5949947b82020-11-25T03:00:54ZengMDPI AGAntibiotics2079-63822020-05-01925925910.3390/antibiotics9050259Detection of Quorum-Sensing Molecules for Pathogenic Molecules Using Cell-Based and Cell-Free BiosensorsCraig Miller0Jordon Gilmore1Bioengineering Department, Clemson University, Clemson, SC 29632, USABioengineering Department, Clemson University, Clemson, SC 29632, USASince the discovery and subsequent use of penicillin, antibiotics have been used to treat most bacterial infections in the U.S. Over time, the repeated prescription of many antibiotics has given rise to many antibiotic-resistant microbes. A bacterial strain becomes resistant by horizontal gene transfer, where surviving microbes acquire genetic material or DNA fragments from adjacent bacteria that encode for resistance. In order to avoid significant bacterial resistance, novel and target therapeutics are needed. Further advancement of diagnostic technologies could be used to develop novel treatment strategies. The use of biosensors to detect quorum-sensing signaling molecules has the potential to provide timely diagnostic information toward mitigating the multidrug-resistant bacteria epidemic. Resistance and pathogenesis are controlled by quorum-sensing (QS) circuits. QS systems secrete or passively release signaling molecules when the bacterial concentration reaches a certain threshold. Signaling molecules give an early indication of virulence. Detection of these compounds in vitro or in vivo can be used to identify the onset of infection. Whole-cell and cell-free biosensors have been developed to detect quorum-sensing signaling molecules. This review will give an overview of quorum networks in the most common pathogens found in chronic and acute infections. Additionally, the current state of research surrounding the detection of quorum-sensing molecules will be reviewed. Followed by a discussion of future works toward the advancement of technologies to quantify quorum signaling molecules in chronic and acute infections.https://www.mdpi.com/2079-6382/9/5/259quorum sensinginfectionbiosensor
collection DOAJ
language English
format Article
sources DOAJ
author Craig Miller
Jordon Gilmore
spellingShingle Craig Miller
Jordon Gilmore
Detection of Quorum-Sensing Molecules for Pathogenic Molecules Using Cell-Based and Cell-Free Biosensors
Antibiotics
quorum sensing
infection
biosensor
author_facet Craig Miller
Jordon Gilmore
author_sort Craig Miller
title Detection of Quorum-Sensing Molecules for Pathogenic Molecules Using Cell-Based and Cell-Free Biosensors
title_short Detection of Quorum-Sensing Molecules for Pathogenic Molecules Using Cell-Based and Cell-Free Biosensors
title_full Detection of Quorum-Sensing Molecules for Pathogenic Molecules Using Cell-Based and Cell-Free Biosensors
title_fullStr Detection of Quorum-Sensing Molecules for Pathogenic Molecules Using Cell-Based and Cell-Free Biosensors
title_full_unstemmed Detection of Quorum-Sensing Molecules for Pathogenic Molecules Using Cell-Based and Cell-Free Biosensors
title_sort detection of quorum-sensing molecules for pathogenic molecules using cell-based and cell-free biosensors
publisher MDPI AG
series Antibiotics
issn 2079-6382
publishDate 2020-05-01
description Since the discovery and subsequent use of penicillin, antibiotics have been used to treat most bacterial infections in the U.S. Over time, the repeated prescription of many antibiotics has given rise to many antibiotic-resistant microbes. A bacterial strain becomes resistant by horizontal gene transfer, where surviving microbes acquire genetic material or DNA fragments from adjacent bacteria that encode for resistance. In order to avoid significant bacterial resistance, novel and target therapeutics are needed. Further advancement of diagnostic technologies could be used to develop novel treatment strategies. The use of biosensors to detect quorum-sensing signaling molecules has the potential to provide timely diagnostic information toward mitigating the multidrug-resistant bacteria epidemic. Resistance and pathogenesis are controlled by quorum-sensing (QS) circuits. QS systems secrete or passively release signaling molecules when the bacterial concentration reaches a certain threshold. Signaling molecules give an early indication of virulence. Detection of these compounds in vitro or in vivo can be used to identify the onset of infection. Whole-cell and cell-free biosensors have been developed to detect quorum-sensing signaling molecules. This review will give an overview of quorum networks in the most common pathogens found in chronic and acute infections. Additionally, the current state of research surrounding the detection of quorum-sensing molecules will be reviewed. Followed by a discussion of future works toward the advancement of technologies to quantify quorum signaling molecules in chronic and acute infections.
topic quorum sensing
infection
biosensor
url https://www.mdpi.com/2079-6382/9/5/259
work_keys_str_mv AT craigmiller detectionofquorumsensingmoleculesforpathogenicmoleculesusingcellbasedandcellfreebiosensors
AT jordongilmore detectionofquorumsensingmoleculesforpathogenicmoleculesusingcellbasedandcellfreebiosensors
_version_ 1724696191823773696